The patients with high CXCL1 expression had 5-year survival of 50% compared to 97% for the patients with low expression, though this did not reach statistical significance ( P = 0.1, Fig. 3 ).
← all excerpts
Four Immune Modulating Genes in Primary Melanoma That Predict Metastatic Potential.
1
0.1000
0.1000